Along with the recommendations on antibiotics, the WHO Expert Committee on the Selection of Essential Medicines urged that an Essential Diagnostics List (EDL) be developed. Like the Essential Medicines List, the EDL would provide evidence-based guidance to countries to create their own national lists of essential diagnostic tests and tools.
National essential medicines lists have been successful in facilitating access to treatment and promoting affordable prices. Particularly in low-resourced countries, this by prioritizing the most important medicines all countries need to make available to their populations.
It is expected that national essential diagnostics lists will provide the same benefits for diagnostic tests. Diagnostic tests play an important role in determining whether a specific drug treatment is indicated or not as well as monitoring for effectiveness or toxicity.
The Committee also noted that Member States might require technical guidance on “which technologies to prioritize, how to shift from one technology to another, and which technologies should accompany essential medicines since they are strongly interconnected”. Towards these ends, WHO is putting together a Strategic Advisory Group of Experts on In Vitro Diagnostics (SAGE IVD). A NEJM perspective piece last year advocated for a Model List of Essential Diagnostics.
These efforts complement earlier discussions by the Foundation for Innovative New Diagnostics (FIND), ReAct, Médecins sans Frontières and WHO to find ways of diagnosing bacterial from other infectious causes of acute fever—an important step to reduce the selective pressure on existing antibiotics.
More from "2017"
- Resistance to last-line antibiotics
- Essential Diagnostics List (EDL) to be developed
- Media workshop in Ecuador: a success
- ReAct withdraws from IMI project DRIVE-AB
- Microbes – friend, foe or both?
- ReAct Asia Pacific hosts workshop on antimicrobial resistance in the farm sector
- Successful antimicrobial resistance media training in Nairobi, Kenya
- Mother Earth, One Health – International Encounter in Argentina
- Key take-aways from the World Health Assembly 2017 on antimicrobial resistance
- National action plans and global AMR framework on the agenda as 70th World Health Assembly kicks off next week
- ReAct co-hosts side event during World Health Assembly
- ReAct supports countries in the development of National Action Plans on AMR
- Lack of access to old antibiotics drives antibiotic resistance development and impairs patient outcomes
- Hand hygiene saves lives
- The Swedish Government awards Reward Medal to Professor Otto Cars
- Presentation of the Alforja Educativa Validation Project enthuses students
- New antibiotics in the news
- Free online course: Antibiotic Resistance: the Silent Tsunami
- Tell Our Bac-Stories!
- India’s link between tuberculosis and antibiotic resistance
- Environmental effects of antibiotics in sewage
- Professor Larsson on India’s National Action Plan on AMR and emissions from antibiotics production
- India’s new National Action Plan on Antimicrobial Resistance
- Professor Otto Cars to serve as Expert in UN Inter-Agency Coordination Group on Antimicrobial Resistance
- Johns Hopkins Bloomberg School of Public Health is looking for a Research Associate
- Could the use of Antimicrobial Peptides create resistance to ourselves?
- Boston Consulting Group report shies away from addressing affordable access and stewardship
- WHO Releases Priority Pathogens List
- Antibiotic Smart Use project nominated for global UN Award
- European Commission diagnostic prize winner announced
- Recap of WHO 140th Executive Board meeting
- New collaboration on strategies for tackling antibiotic resistance